95.29
price down icon6.62%   -6.76
after-market Handel nachbörslich: 94.50 -0.79 -0.83%
loading
Schlusskurs vom Vortag:
$102.05
Offen:
$101.95
24-Stunden-Volumen:
63,059
Relative Volume:
1.21
Marktkapitalisierung:
$587.94M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.12M
KGV:
-41.43
EPS:
-2.3
Netto-Cashflow:
$-6.82M
1W Leistung:
-3.28%
1M Leistung:
+93.60%
6M Leistung:
+154.17%
1J Leistung:
+1,668%
1-Tages-Spanne:
Value
$94.54
$104.00
1-Wochen-Bereich:
Value
$86.26
$104.00
52-Wochen-Spanne:
Value
$4.50
$105.00

Monopar Therapeutics Inc Stock (MNPR) Company Profile

Name
Firmenname
Monopar Therapeutics Inc
Name
Telefon
(847) 388-0349
Name
Adresse
1000 SKOKIE BLVD SUITE 350, WILMETTE
Name
Mitarbeiter
16
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
MNPR's Discussions on Twitter

Vergleichen Sie MNPR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MNPR
Monopar Therapeutics Inc
95.29 629.64M 0 -7.12M -6.82M -2.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-09 Eingeleitet BTIG Research Buy
2025-09-03 Eingeleitet Oppenheimer Outperform
2025-09-03 Eingeleitet Raymond James Strong Buy
2025-08-26 Fortgesetzt H.C. Wainwright Buy
2025-07-07 Eingeleitet Cantor Fitzgerald Overweight
2025-06-23 Eingeleitet Chardan Capital Markets Buy
2025-03-19 Fortgesetzt Piper Sandler Overweight
2025-01-10 Eingeleitet Piper Sandler Overweight
2024-10-11 Eingeleitet Rodman & Renshaw Buy
2021-01-28 Eingeleitet ROTH Capital Buy
Alle ansehen

Monopar Therapeutics Inc Aktie (MNPR) Neueste Nachrichten

pulisher
07:20 AM

Key metrics from Monopar Therapeutics Inc.’s quarterly dataTrade Analysis Summary & Safe Capital Growth Trade Ideas - newser.com

07:20 AM
pulisher
05:22 AM

Is Monopar Therapeutics Inc. forming a reversal patternQuarterly Portfolio Review & Daily Profit Focused Screening - newser.com

05:22 AM
pulisher
01:23 AM

Monopar Therapeutics (NASDAQ:MNPR) Trading Up 16.3% After Analyst Upgrade - Defense World

01:23 AM
pulisher
Oct 13, 2025

Is Monopar Therapeutics Inc. stock safe for conservative investorsWeekly Trade Recap & Free High Return Stock Watch Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Multi factor analysis applied to Monopar Therapeutics Inc.2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Will Monopar Therapeutics Inc. stock recover faster than peersJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

MNPR: Barclays Initiates Coverage with Overweight Rating | MNPR Stock News - GuruFocus

Oct 13, 2025
pulisher
Oct 13, 2025

This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Oct 13, 2025
pulisher
Oct 13, 2025

Monopar Therapeutics initiated with an Overweight at Barclays - TipRanks

Oct 13, 2025
pulisher
Oct 13, 2025

Heatmap analysis for Monopar Therapeutics Inc. and competitors2025 Key Lessons & Daily Volume Surge Trade Alerts - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Real time social sentiment graph for Monopar Therapeutics Inc.Weekly Trade Recap & Free Community Consensus Stock Picks - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Monopar Therapeutics (NASDAQ:MNPR) Raised to Strong-Buy at Jones Trading - Defense World

Oct 12, 2025
pulisher
Oct 11, 2025

Monopar Therapeutics (NASDAQ:MNPR) Stock Price Down 12.3%Here's What Happened - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Monopar Therapeutics (NASDAQ:MNPR) Upgraded to "Strong-Buy" at Jones Trading - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

Monopar Therapeutics: A Healthy Dose Of Skepticism Warranted (NASDAQ:MNPR) - Seeking Alpha

Oct 10, 2025
pulisher
Oct 10, 2025

Institutional scanner results for Monopar Therapeutics Inc.2025 Momentum Check & High Win Rate Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Monopar Therapeutics' (MNPR) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Monopar Therapeutics Inc.: Promising Prospects with ALXN1840 Acquisition and Wilson’s Disease Market Potential - TipRanks

Oct 10, 2025
pulisher
Oct 10, 2025

What analysts say about Monopar Therapeutics Inc stockProtective Put Strategies & Low Risk Investment Trading - earlytimes.in

Oct 10, 2025
pulisher
Oct 09, 2025

How Monopar Therapeutics Inc. (1IY0) stock reacts to monetary easingJuly 2025 Breakouts & Precise Trade Entry Recommendations - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Raymond James Maintains Monopar Therapeutics (MNPR) Strong Buy Recommendation - Nasdaq

Oct 06, 2025
pulisher
Oct 06, 2025

MNPR: Raymond James Raises Price Target to $142, Maintains Stron - GuruFocus

Oct 06, 2025
pulisher
Oct 06, 2025

Monopar Therapeutics (NASDAQ:MNPR) Hits New 1-Year HighTime to Buy? - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

How to integrate Monopar Therapeutics Inc. into portfolio analysis toolsWatch List & Fast Gaining Stock Strategy Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Historical volatility pattern of Monopar Therapeutics Inc. visualizedTrade Entry Summary & Entry Point Strategy Guides - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Monopar Therapeutics Inc. (1IY0) stock beat Nasdaq index returnsTrade Risk Summary & Long-Term Safe Investment Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Risk adjusted return profile for Monopar Therapeutics Inc. analyzedJuly 2025 Big Picture & High Return Stock Watch Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Can trapped investors hope for a rebound in Monopar Therapeutics Inc.Watch List & Fast Entry Momentum Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Monopar Therapeutics Inc. (1IY0) stock overpriced at current multiplesJuly 2025 Recap & Entry Point Confirmation Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Using portfolio simulators with Monopar Therapeutics Inc. includedJuly 2025 Retail & Reliable Price Breakout Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Analyzing Monopar Therapeutics Inc. with risk reward ratio chartsGlobal Markets & Community Shared Stock Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Can volume confirm reversal in Monopar Therapeutics Inc.July 2025 Macro Moves & Reliable Price Breakout Signals - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Oppenheimer Maintains Monopar Therapeutics (MNPR) Outperform Recommendation - Nasdaq

Oct 02, 2025
pulisher
Oct 02, 2025

Oppenheimer Raises Price Target for Monopar Therapeutics (MNPR) - GuruFocus

Oct 02, 2025

Finanzdaten der Monopar Therapeutics Inc-Aktie (MNPR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Monopar Therapeutics Inc-Aktie (MNPR) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Tsuchimoto Kim R
Director
Jul 14 '25
Sale
40.00
8,904
356,171
11,486
STARR CHRISTOPHER M
Director
Jul 14 '25
Sale
40.00
16,800
672,020
5,173
Robinson Chandler
Chief Executive Officer
Jul 14 '25
Sale
40.00
16,800
672,020
73,472
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):